Home / Inspections / 1271223

FDA Inspection 1271223 — Janssen Pharmaceuticals, Inc

Janssen Pharmaceuticals, Inc — FEI 2242843

The FDA completed an inspection of Janssen Pharmaceuticals, Inc on August 14, 2025 in Titusville, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 14, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Titusville, NJ (United States)

Facility

Other inspections at this facility

  • 1229931 (VAI Fri Sep 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1131617 (NAI Mon Sep 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1131381 (NAI Mon Sep 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1031605 (NAI Fri Oct 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 923153 (NAI Wed Apr 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources